Private Advisor Group’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $36.9K | Buy |
29,769
+6,386
| +27% | +$7.92K | ﹤0.01% | 2357 |
|
|
2025
Q1 | $27.6K | Sell |
23,383
-2,625
| -10% | -$3.1K | ﹤0.01% | 2252 |
|
|
2024
Q4 | $47.6K | Sell |
26,008
-1,853
| -7% | -$3.39K | ﹤0.01% | 2211 |
|
|
2024
Q3 | $47.4K | Buy |
27,861
+143
| +0.5% | +$243 | ﹤0.01% | 2350 |
|
|
2024
Q2 | $38K | Buy |
27,718
+2,385
| +9% | +$3.27K | ﹤0.01% | 2281 |
|
|
2024
Q1 | $95K | Buy |
25,333
+5,942
| +31% | +$22.3K | ﹤0.01% | 2202 |
|
|
2023
Q4 | $190K | Sell |
19,391
-349
| -2% | -$3.42K | ﹤0.01% | 2052 |
|
|
2023
Q3 | $165K | Buy |
19,740
+2,027
| +11% | +$16.9K | ﹤0.01% | 1889 |
|
|
2023
Q2 | $236K | Buy |
17,713
+4,402
| +33% | +$58.5K | ﹤0.01% | 1770 |
|
|
2023
Q1 | $154K | Buy |
13,311
+500
| +4% | +$5.79K | ﹤0.01% | 1824 |
|
|
2022
Q4 | $105 | Sell |
12,811
-900
| -7% | -$7 | ﹤0.01% | 1577 |
|
|
2022
Q3 | $80K | Sell |
13,711
-1,458
| -10% | -$8.51K | ﹤0.01% | 1800 |
|
|
2022
Q2 | $67K | Sell |
15,169
-4,377
| -22% | -$19.3K | ﹤0.01% | 1988 |
|
|
2022
Q1 | $178K | Buy |
19,546
+59
| +0.3% | +$537 | ﹤0.01% | 1916 |
|
|
2021
Q4 | $399K | Buy |
19,487
+3,300
| +20% | +$67.6K | ﹤0.01% | 1574 |
|
|
2021
Q3 | $414K | Sell |
16,187
-400
| -2% | -$10.2K | ﹤0.01% | 1595 |
|
|
2021
Q2 | $580K | Sell |
16,587
-851
| -5% | -$29.8K | 0.01% | 1318 |
|
|
2021
Q1 | $581K | Buy |
17,438
+2,552
| +17% | +$85K | 0.01% | 1229 |
|
|
2020
Q4 | $386K | Buy |
14,886
+566
| +4% | +$14.7K | ﹤0.01% | 1345 |
|
|
2020
Q3 | $141K | Buy |
14,320
+7,755
| +118% | +$76.4K | ﹤0.01% | 1457 |
|
|
2020
Q2 | $23K | Buy |
+6,565
| New | +$23K | ﹤0.01% | 2502 |
|
|
2019
Q4 | – | Sell |
-10,000
| Closed | -$52K | – | 1701 |
|
|
2019
Q3 | $52K | Buy |
+10,000
| New | +$52K | ﹤0.01% | 1588 |
|